Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy

International Immunopharmacology

Volumn 11, Issue 11, 2011, Pages 1877-1886

  Soto, Brenda L ^a   Hank, Jacquelyn A ^a,c   Darjatmoko, Soesiawati R ^b   Polans, Arthur S ^b   Yanke, Eric M ^b   Rakhmilevich, Alexander L ^a,c   Seo, Songwon ^b,c   Kim, Kyungmann ^b,c   Reisfeld, Ralph A ^d   Gillies, Stephen D ^e   Sondel, Paul M ^a,b,c  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e Provenance Biopharmaceuticals Corp   (United States)

Author keywords

Anti GD2 antibody; hu14.18 IL2; Immunocytokine; Neuroblastoma; Resveratrol

Indexed keywords

INTERLEUKIN 2; MITOGENIC AGENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HU14 18; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG CYTOTOXICITY; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TUMOR CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOTHERAPY; LEUKOCYTES, MONONUCLEAR; MICE; MICE, NUDE; NEOPLASMS; SPLEEN; STILBENES;

EID: 80055003425     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.07.019     Document Type: Article

References (36)

1. P. Langcake, and R.J. Pryce The production of Resveratrol by Vitis vinefra and other members of the Vitaceae as a response of infection or injury Physiol Plant Pahtol 9 1976 77 86
2. F. Orallo Comparative studies of the antioxidant effects of cis- and trans-resveratrol Curr Med Chem 13 2006 87 98
3. W.H. Chan, and Y.J. Chang Dosage effects of resveratrol on ethanol-induced cell death in the human K562 cell line Toxicol Lett 161 2006 1 9
4. Y. Chen, S.H. Tseng, H.S. Lai, and W.J. Chen Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice Surgery 136 2004 57 66 (Pubitemid 38834220)
5. M.P. Fuggetta, S. D'Atri, G. Lanzilli, M. Tricarico, E. Cannavo, and G. Zambruno In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide Melanoma Res 14 2004 189 196 (Pubitemid 38879580)
6. X. Gao, D. Deeb, J. Media, G. Divine, H. Jiang, and R.A. Chapman Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects Biochem Pharamacol 66 2003 2427 2435 (Pubitemid 37456749)
7. X. Gao, Y.X. Xu, N. Janakiraman, R.A. Chapman, and S.C. Gautam Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production Biochem Pharmacol 62 2001 1299 1308 (Pubitemid 33055634)
8. H.S. Liu, C.E. Pan, W. Yang, and X.M. Liu Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice World J Gastroenterol 9 2003 1474 1476 (Pubitemid 36992335)
9. S. Reagan-Shaw, F. Afaq, M.H. Aziz, and N. Ahmad Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin Oncogene 23 2004 5151 5160 (Pubitemid 38980348)
10. F. Scarlatti, G. Sala, G. Somenzi, P. Signorelli, N. Sacchi, and R. Ghidoni Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling FASEB J 17 2003 2339 2341 (Pubitemid 39561486)
11. P. Signorelli, and R. Ghidoni Resveratrol as an anticancer nutrient: molecular basis, open questions and promises J Nutr Biochem 16 2005 449 466 (Pubitemid 41039220)
12. P.R. van Ginkel, D. Sareen, L. Subramanian, Q. Walker, S.R. Darjatmoko, and M.J. Lindstrom Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria Clin Cancer Res 13 2007 5162 5169 (Pubitemid 47502085)
13. S. Yang, and F.L. Meyskens Alterations in activating protein 1 composition correlate with phenotypic differentiation changes induced by resveratrol in Human melanoma Mol Pharmacol 67 2005 298 308 (Pubitemid 40069991)
14. D. Bernhard, I. Tinhofer, M. Tonko, H. Hubi, M.J. Ausseriechner, and R. Greil Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in the CEM-C7H2 acute leukemia cells Cell Death Differ 7 2000 834 842
15. A.R. Jazirehi, and B. Bonavida Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis Mol Cancer Ther 3 2004 71 84 (Pubitemid 39193680)
16. R.M. Niles, M. McFarland, M.B. Weimer, A. Redkar, Y.M. Fu, and G.G. Meadows Resveratrol is a potent inducer of apoptosis in human melanoma cells Cancer Lett 190 2003 157 163 (Pubitemid 36136014)
17. S.J. Zunino, and D.H. Storms Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore Cancer Lett 240 2005 123 134 (Pubitemid 44037172)
18. S.J. Zunino, and D.H. Storms Resveratrol alters proliferative responses and apoptosis in human activated B lymphocytes in vitro J Nutr 139 2009 1603 1608
19. P. Boscolo, A. del Signore, E. Sabbioni, M. Di Gioacchino, L. Di Giampaolo, and M. Reale Effects of resveratrol on lymphocyte proliferation and cytokine release Ann Clin Lab Sci 33 2003 226 231 (Pubitemid 36705934)
20. R. Falchetti, M.P. Fuggetta, G. Lanzilli, M. Tricarico, and G. Ravagnan Effects of resveratrol on human immune cell function Life Sci 70 2001 81 96 (Pubitemid 33124357)
21. Y.H. Feng, W.L. Zhou, Q.L. Wu, X.Y. Li, W.M. Zhao, and J.P. Zou Low dose of resveratrol enhanced immune response of mice Acta Pharmacol Sin 23 2002 893 897
22. T. Kubota, Y. Uemura, M. Kobayashi, and H. Taguchi Combined effects of resveratrol and paclitaxel on lung cancer cells Anticancer Res 23 2003 4039 4046 (Pubitemid 37474362)
23. S.L. Wu, Z.J. Sun, L. Yu, K.W. Meng, X.L. Qin, and C.E. Pan Effect of resveratrol in combination with 5-FU on murine liver cancer Pharmacol Res 10 2004 3048 3052 (Pubitemid 39303061)
24. K. Mujoo, D. Cheresh, H.M. Yang, and R.A. Reisfeld Disialoganglioside GD2 on human neuroblastoma: target antigen for monoclonal antibody mediated cytolysis and suppression of tumor growth Cancer Res 47 1986 1098 1104
25. Z.C. Neal, J.C. Yang, A.L. Rakhmilevich, I.N. Buhtoiarov, H.E. Lum, and M. Imboden Enhanced activity of hu14.18-IL2 immunocytokine against murine NXS2 neuroblastoma when combined with interleukin 2 therapy Clin Cancer Res 10 2004 4839 4847 (Pubitemid 38955538)
26. G.A. Lammie, N.K.V. Cheung, W. Gerald, M. Rosenblum, and C. Cordon-Cardo Ganglioside GD2 expression in the human nervous system and in neuroblastomas: an immunohistochemical study Int J Oncol 3 1993 909 915 (Pubitemid 23343504)
27. G. Schulz, D.A. Cheresh, N.M. Varki, A. Yu, L.K. Staffileno, and R.A. Reisfeld Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients Cancer Res 44 1984 5914 5920 (Pubitemid 15183611)
28. J.A. Hank, R.R. Robinson, J. Surfus, B.M. Mueller, R.A. Reisfeld, and N.K. Cheung Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant Interleukin 2 Cancer Res 50 1990 5234 5239 (Pubitemid 20302968)
29. E.E. Johnson, H.D. Lum, A.L. Rakhmilevich, B.E. Schmidt, M. Furlong, and I.N. Buhtoiarov Intratumoral immunocytokine treatment results in enhanced antitumor effects Cancer Immunol Immunother 57 2008 1891 1902
30. I.N. Buhtoiarov, H. Lum, G. Berke, D.M. Paulnock, P.M. Sondel, and A.L. Rakhmilevich CD40 ligation activates murine macrophages via an IFN-gamma-dependent mechanism resulting in tumor cell destruction in vitro J Immunol 174 2005 6013 6022 (Pubitemid 40663788)
31. T.C. Hsieh, Z. Wang, C.V. Hamby, and J.M. Wu Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53 Biochem Biophys Res Commun 334 2005 223 230 (Pubitemid 40978529)
32. B.B. Aggarwal, and S. Shishodia Molecular targets of dietary agents for prevention and therapy of cancer Biochem Pharmacol 71 2006 1397 1421
33. S.M. Meeran, and S.K. Katiyar Cell cycle control as a basis for cancer chemoprevention through dietary agents Front Biosci 13 2008 2191 2202 (Pubitemid 351589245)
34. S. Pervaiz, and A.L. Holme Resveratrol: its biologic targets and functional activity Antioxid Redox Signal 11 2009 2851 2897
35. K.R. Landis-Piwowar, V. Milacic, D. Chen, H. Yang, Y. Zhao, and T.H. Chan The proteasome as a potential target for novel anticancer drugs and chemosensitizers Drug Resist Updat 9 2006 263 273 (Pubitemid 46357634)
36. B.L. Soto, J.A. Hank, T.J. Van De Voort, L. Subramanian, A.S. Polans, and A.L. Rakhmilevich The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model Cancer Immunol Immunother 60 2011 731 738